Koselugo Granule
Product Images NDC 0310-0635

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Koselugo (NDC 0310-0635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Chemicalstructure Selumetinib)

Chemical structure of selumetinib sulfate, the active ingredient in KOSELUGO capsules by AstraZeneca Pharmaceuticals LP. The structure shows the molecular arrangement including hydroxyl, amide, halogen (chlorine, bromine, fluoride), and methyl groups as part of the compound complexed with sulfuric acid (H2SO4).*

FDA Label Image

Step_1 (Step 1)

An instructional black-and-white illustration showing hands being washed under a running faucet with water droplets depicted. The image emphasizes handwashing technique with visible water flow and splashes.*

FDA Label Image

Step_2 (Step 2)

An instructional illustration showing a hand pouring capsules from a bottle into the palm of another hand. The capsules are detailed with a face-like design, suggesting user-friendly imagery typically used for medication handling instructions.*

FDA Label Image

Step_3 (Step 3)

An illustration showing a spoon and a cup, each containing a gray powder. The spoon has a small heap of powder, while the cup holds a larger quantity. The image likely represents measuring or preparing a powder form of medication or supplement.*

FDA Label Image

Step_4 (Step 4)

An instructional illustration showing two capsules being opened and their contents emptied; one capsule's contents are poured onto a spoon, and the other into a cup or small container with liquid, demonstrating different ways to administer capsule contents.*

FDA Label Image

Step_5 (Step 5)

Illustration depicting a caregiver administering oral medication to a child using a spoon. The child is shown in profile with mouth open, and the caregiver's hand is positioned to deliver the dose by spoon.*

FDA Label Image

Step_6 (Step 6)

An illustration showing a container or glass with granules or small pellets at the bottom, placed on a plate. The image likely represents a pharmaceutical dosage form or method of administration involving granules or pellets in a cup.*

FDA Label Image

10mg 28count (10mgpdp)

Koselugo (selumetinib) 10 mg capsules label for oral use. The label indicates prescription-only status, with instructions to dispense in the original bottle and not to remove the desiccant. It also notes the package contains 28 capsules. The labeler is AstraZeneca Pharmaceuticals LP.*

FDA Label Image

25mg 28ct (25mgpdp)

Koselugo (selumetinib) 25 mg capsules label for oral administration, manufactured by AstraZeneca Pharmaceuticals LP. The label includes storage instructions to keep the original bottle closed with the desiccant and indicates a package containing 28 capsules.*

FDA Label Image

5mg_oral_granules (5mg Oral Granules)

KOSELUGO 5 mg oral granules capsule label by AstraZeneca Pharmaceuticals LP. The label highlights the active ingredient selumetinib and instructs users to sprinkle the granules on or mix with yogurt or fruit puree. It details storage below 25°C (77°F) and protection from light and moisture. The package contains 60 capsules and is marked Rx only.*

FDA Label Image

7_5mg_oral_granules (7 5mg Oral Granules)

KOSELUGO (selumetinib) oral granules 7.5 mg label with instructions to sprinkle oral granules on or mix with smooth yogurt or fruit puree. The label indicates storage below 25°C (77°F) to protect from light and moisture. It contains 60 capsules and is manufactured by AstraZeneca Pharmaceuticals LP. Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.